Quick Summary TreeFrog Therapeutics announced preclinical data for TFG‑001, a 3D neural microtissue therapy for Parkinson’s disease. The approach aims to replace damaged dopamine‑producing neurons. Preclinical models showed rapid dopamine release, nerve regrowth, and motor recovery. However, the work is still preclinical; a Clinical Trial Application is expected in 2027.
Quick Summary Stem cell therapy for Alzheimer’s uses mesenchymal stem cells (MSCs), neural stem cells (NSCs), or induced pluripotent stem cells (iPSCs) to repair damaged brain cells, reduce inflammation, and support the central nervous system. Early-stage patients may see improved memory and slower decline, but treatment is not yet a
Quick Read Summary When a loved one faces Alzheimer’s, families need realistic expectations for stem cell therapy in Alzheimer’s disease what families need to know. Stem cell treatment uses mesenchymal stem cells mscs and other adult stem cells to release growth factors that may support brain health. However, stem cell
